# Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease

> **NCT04002596** · NA · COMPLETED · sponsor: **InSightec** · enrollment: 10 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** ExAblate Neuro Thalamotomy Treatment

## Key facts

- **NCT ID:** NCT04002596
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-06
- **Primary completion:** 2018-12-05
- **Final completion:** 2019-09-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04002596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04002596, "Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04002596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*